SPS
FOLD

Susquehanna Portfolio Strategies’s Amicus Therapeutics FOLD Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.5M Hold
1,075,323
– – 0.23% 120
2025
Q4 		$15.3M Hold
1,075,323
– – 0.24% 117
2025
Q3 		$8.47M Sell
1,075,323
-183,936
-15% -$1.31M 0.13% 219
2025
Q2 		$7.22M Buy
+1,259,259
New +$8.13M 0.16% 181

Other funds holding FOLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Susquehanna Portfolio Strategies's FOLD Position: Q1 2026 in Review

Susquehanna Portfolio Strategies held its Amicus Therapeutics (FOLD) position steady in Q1 2026 at 1,075,323 shares worth $15.5M. The position accounts for 0.23% of the portfolio, ranked #120.

Susquehanna Portfolio Strategies first reported a position in FOLD in Q2 2025 and has held it in 4 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Susquehanna Portfolio Strategies held 1,075,323 shares of Amicus Therapeutics worth $15.5M as of Q1 2026.
  • Susquehanna Portfolio Strategies left its Amicus Therapeutics share count unchanged in Q1 2026.
  • Amicus Therapeutics made up 0.23% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #120 holding.
  • Susquehanna Portfolio Strategies first reported a position in Amicus Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.